» Articles » PMID: 33828529

Nutrition and Obesity in the Pathogenesis of Youth-Onset Type 1 Diabetes and Its Complications

Overview
Specialty Endocrinology
Date 2021 Apr 8
PMID 33828529
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Since the 1980s, there has been a dramatic rise in the prevalence of overweight and obesity in pediatric populations, in large part driven by sedentary lifestyles and changing dietary patterns with more processed foods. In parallel with the rise in pediatric obesity in the general population, the prevalence of overweight and obesity has increased among children and adolescents with type 1 diabetes. Adiposity has been implicated in a variety of mechanisms both potentiating the risk for type 1 diabetes as well as exacerbating long-term complications, particularly cardiovascular disease. Treatment options targeting the unique needs of obese pediatric patients, both before and after diagnosis of type 1 diabetes, are limited. In this review, we discuss the history of the epidemiology of the obesity epidemic in the context of pediatric type 1 diabetes, highlight the possible role of obesity in type 1 diabetes pathogenesis and review the concept of "double diabetes". The impact of obesity at and after diagnosis will be discussed, including noted differences in clinical and biochemical markers, lipid abnormalities, and long-term cardiovascular complications. Finally, we will review the existing literature on pharmacologic and nutritional interventions as potential treatment strategies for youth with coexisting type 1 diabetes and obesity.

Citing Articles

An adipocentric perspective of pancreatic lipotoxicity in diabetes pathogenesis.

Risi R, Vidal-Puig A, Bidault G J Endocrinol. 2024; 262(1).

PMID: 38642584 PMC: 11227041. DOI: 10.1530/JOE-23-0313.


A multi-centre investigation of macrovascular and non-ocular microvascular complications in children and adolescents with diabetes mellitus in southern Ghana.

Akpalu J, Essuman V, Amoaku W, Abaidoo B, Essuman A, Hayfron-Benjamin C Ghana Med J. 2024; 57(2):87-96.

PMID: 38504754 PMC: 10846650. DOI: 10.4314/gmj.v57i2.2.


The Association between Dietary Pattern, Obesity, and Glycemic Control of Children and Adolescents with Type 1 Diabetes Mellitus.

da Cunha L, Carvalho Ramos Salles de Oliveira D, de Oliveira Cardoso L, Sartorelli D, Xavier Peniche B, de Araujo B Nutrients. 2024; 16(3).

PMID: 38337649 PMC: 10856978. DOI: 10.3390/nu16030364.


The Causal Effect of Obesity on the Risk of 15 Autoimmune Diseases: A Mendelian Randomization Study.

Li X, Zhu J, Zhao W, Zhu Y, Zhu L, Shi R Obes Facts. 2023; 16(6):598-605.

PMID: 37827145 PMC: 10697740. DOI: 10.1159/000534468.


Urinary epidermal growth factor reflects vascular health in boys with either obesity or type 1 diabetes. A role for renin, or beyond?.

Ledeganck K, Van Eyck A, Wouters K, Vermeiren E, De Winter B, Verhulst S PLoS One. 2023; 18(3):e0283716.

PMID: 36996194 PMC: 10062545. DOI: 10.1371/journal.pone.0283716.


References
1.
Marroqui L, Dos Santos R, Op de Beeck A, Coomans de Brachene A, Marselli L, Marchetti P . Interferon-α mediates human beta cell HLA class I overexpression, endoplasmic reticulum stress and apoptosis, three hallmarks of early human type 1 diabetes. Diabetologia. 2017; 60(4):656-667. DOI: 10.1007/s00125-016-4201-3. View

2.
Redondo M, Geyer S, Steck A, Sosenko J, Anderson M, Antinozzi P . Genetic Variants Contribute to Phenotypic Heterogeneity of Type 1 Diabetes. Diabetes Care. 2017; 41(2):311-317. PMC: 5780048. DOI: 10.2337/dc17-0961. View

3.
Freedman D, Mei Z, Srinivasan S, Berenson G, Dietz W . Cardiovascular risk factors and excess adiposity among overweight children and adolescents: the Bogalusa Heart Study. J Pediatr. 2006; 150(1):12-17.e2. DOI: 10.1016/j.jpeds.2006.08.042. View

4.
Biester T, Aschemeier B, Fath M, Frey M, Scheerer M, Kordonouri O . Effects of dapagliflozin on insulin-requirement, glucose excretion and ß-hydroxybutyrate levels are not related to baseline HbA1c in youth with type 1 diabetes. Diabetes Obes Metab. 2017; 19(11):1635-1639. DOI: 10.1111/dom.12975. View

5.
Lyons S, Hermann J, Miller K, Hofer S, Foster N, Rami-Merhar B . Use of Adjuvant Pharmacotherapy in Type 1 Diabetes: International Comparison of 49,996 Individuals in the Prospective Diabetes Follow-up and T1D Exchange Registries. Diabetes Care. 2017; 40(10):e139-e140. PMC: 6463738. DOI: 10.2337/dc17-0403. View